Showing results (81-90 of 250) with videos related to
Sort By:
Pageof 25
Oncology (Williston Park, N.Y.)|November 27, 1998
The oral fluorouracil prodrugsR Pazdur, P M Hoff, D Medgyesy, et al.Cancer|May 15, 1980
Vinblastine (VLB), bleomycin (BLEO), cis-diamminedichloroplatinum (DDP) in disseminated extragonadal germ cell tumors. A Southwest Oncology Group StudyL G Feun, M K Samson, R L StephensAmerican Journal of Clinical Oncology|December 1, 1989
Low-dose continuous infusion 5-fluorouracil and cisplatin: phase II evaluation in advanced colorectal carcinomaP LoRusso, R Pazdur, B G Redman, et al.Cancer Treatment Reports|December 1, 1986
Phase II trial of mitomycin, vindesine, and hexamethylmelamine in metastatic non-small cell bronchogenic carcinomaP D Bonomi, R Pazdur, L Stolbach, et al.Anti-Cancer Drugs|September 1, 1996
Phase I trials of uracil-tegafur (UFT) using 5 and 28 day administration schedules: demonstration of schedule-dependent toxicitiesR Pazdur, Y Lassere, E Diaz-Canton, et al.The American Journal of Gastroenterology|October 1, 1995
Psychological distress in patients with gastroesophageal reflux diseaseL H Baker, D Lieberman, M OehlkeCancer|February 1, 1989
Metoclopramide versus metoclopramide and lorazepam. Superiority of combined therapy in the control of cisplatin-induced emesisC J Gordon, R Pazdur, A Ziccarelli, et al.The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|April 7, 1999
Effects of age on balance assessment using voluntary and involuntary step tasksC W Luchies, D Wallace, R Pazdur, et al.Investigational New Drugs|November 11, 1992
Phase II study of gemcitabine in advanced colorectal adenocarcinomaD F Moore, R Pazdur, K Daugherty, et al.Pageof 25